NCT01896830View on ClinicalTrials.gov

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

June 30, 2014

Conditions
Clostridium Difficile Infection
Interventions
BIOLOGICAL

Clostridium difficile Toxoid Vaccine

0.5 mL, intramuscular

BIOLOGICAL

0.9% normal saline

0.5 mL, intramuscular

Trial Locations (1)

532-0003

Osaka

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01896830 - Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan | Biotech Hunter | Biotech Hunter